Translational Cancer Research : Impact Factor & More
eISSN: 2219-6803pISSN: 2218-676X
Share this on:
Key Metrics
CiteScore 
0.8
Impact Factor
< 5
SJR
Q4Oncology
SNIP
0.16
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Translational Cancer Research
Translational Cancer Research Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Translational Cancer Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Translational Cancer Research
Clinicopathological characteristics and prognosis of breast carcinoma with apocrine differentiation: a propensity score-matched analysis of the SEER database
- 1 Jul 2026
- Translational Cancer Research
Dynamic tumor tracking for locally advanced pancreatic cancer: precision in motion.
- 30 Jun 2026
- Translational cancer research
Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials.
- 30 Jun 2026
- Translational cancer research
Do we need to adapt the American Joint Committee on Cancer staging system after neo-adjuvant treatment in esophageal squamous cell carcinoma?
- 30 Jun 2026
- Translational cancer research
Venous thromboembolism risk in sarcoma patients receiving combined immune checkpoint inhibitors and VEGF pathway inhibitors: a real-world cohort study.
- 30 Jun 2026
- Translational cancer research
METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer.
- 30 Jun 2026
- Translational cancer research
Clinicopathological characteristics and prognosis of breast carcinoma with apocrine differentiation: a propensity score-matched analysis of the SEER database
- 1 Jul 2026
- Translational Cancer Research
Dynamic tumor tracking for locally advanced pancreatic cancer: precision in motion.
- 30 Jun 2026
- Translational cancer research
Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials.
- 30 Jun 2026
- Translational cancer research
Do we need to adapt the American Joint Committee on Cancer staging system after neo-adjuvant treatment in esophageal squamous cell carcinoma?
- 30 Jun 2026
- Translational cancer research
Venous thromboembolism risk in sarcoma patients receiving combined immune checkpoint inhibitors and VEGF pathway inhibitors: a real-world cohort study.
- 30 Jun 2026
- Translational cancer research
METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer.
- 30 Jun 2026
- Translational cancer research
FAQs on Translational Cancer Research
How long has Translational Cancer Research been actively publishing? 
What is the publishing frequency of Translational Cancer Research?
How many articles did Translational Cancer Research publish last year?
What is the eISSN & pISSN for Translational Cancer Research?
What is Citescore for Translational Cancer Research?
What is SNIP score for Translational Cancer Research?
What is the SJR for Translational Cancer Research?
Who is the publisher of Translational Cancer Research?
